933 related articles for article (PubMed ID: 29803839)
1. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
[TBL] [Abstract][Full Text] [Related]
2. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
3. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
4. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
[TBL] [Abstract][Full Text] [Related]
5. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
6. Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms.
Kamata K; Takenaka M; Minaga K; Omoto S; Miyata T; Yamao K; Imai H; Nakai A; Tanaka H; Chiba Y; Watanabe T; Sakurai T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kitano M; Kudo M
Dig Endosc; 2018 Sep; 30(5):659-666. PubMed ID: 29675938
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
8. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
[TBL] [Abstract][Full Text] [Related]
9. Refinement of screening for familial pancreatic cancer.
Bartsch DK; Slater EP; Carrato A; Ibrahim IS; Guillen-Ponce C; Vasen HF; Matthäi E; Earl J; Jendryschek FS; Figiel J; Steinkamp M; Ramaswamy A; Vázquez-Sequeiros E; Muñoz-Beltran M; Montans J; Mocci E; Bonsing BA; Wasser M; Klöppel G; Langer P; Fendrich V; Gress TM
Gut; 2016 Aug; 65(8):1314-21. PubMed ID: 27222532
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Cancer Surveillance in Carriers of a Germline
Klatte DCF; Boekestijn B; Wasser MNJM; Feshtali Shahbazi S; Ibrahim IS; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Dekker FW; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME
J Clin Oncol; 2022 Oct; 40(28):3267-3277. PubMed ID: 35658523
[TBL] [Abstract][Full Text] [Related]
11. High Growth Rate of Pancreatic Ductal Adenocarcinoma in
Ibrahim IS; Wasser MN; Wu Y; Inderson A; de Vos Tot Nederveen Cappel WH; Morreau H; Hes FJ; Veenendaal RA; Putter H; Feshtali S; van Mil AM; Gruis NA; Tollenaar RA; Bergman W; Bonsing BA; Vasen HFA
Cancer Prev Res (Phila); 2018 Sep; 11(9):551-556. PubMed ID: 29991580
[No Abstract] [Full Text] [Related]
12. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
Chhoda A; Vodusek Z; Wattamwar K; Mukherjee E; Gunderson C; Grimshaw A; Sharma A; Ahuja N; Kastrinos F; Farrell JJ
Gastroenterology; 2022 Mar; 162(3):786-798. PubMed ID: 34813861
[TBL] [Abstract][Full Text] [Related]
13. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
[TBL] [Abstract][Full Text] [Related]
16. Natural history of intraductal papillary mucinous neoplasm and non-neoplastic cyst: long-term imaging follow-up study.
Hisada Y; Nagata N; Imbe K; Takasaki Y; Sekine K; Tajima T; Yanase M; Fujimoto K; Akiyama J; Uemura N
J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):401-408. PubMed ID: 28512773
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.
Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B
World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534
[TBL] [Abstract][Full Text] [Related]
18. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
[TBL] [Abstract][Full Text] [Related]
19. High-grade pancreatic intraepithelial lesions: prevalence and implications in pancreatic neoplasia.
Park JR; Li F; Oza VM; Sklaw BC; Cronley KM; Wellner M; Swanson B; Krishna SG
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):202-208. PubMed ID: 28381386
[TBL] [Abstract][Full Text] [Related]
20. A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.
Harinck F; Konings IC; Kluijt I; Poley JW; van Hooft JE; van Dullemen HM; Nio CY; Krak NC; Hermans JJ; Aalfs CM; Wagner A; Sijmons RH; Biermann K; van Eijck CH; Gouma DJ; Dijkgraaf MG; Fockens P; Bruno MJ;
Gut; 2016 Sep; 65(9):1505-13. PubMed ID: 25986944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]